Delta Accumulation, LLC Bristol Myers Squibb CO Call Options Transaction History

Delta Accumulation, LLC

10 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q3 2024 Nov 12, 2024	SELL	$39.66 - $51.75 $483,851 - $631,350	-12,200 Reduced 17.68%	56,800 $2.94 Million
Q2 2024 Aug 09, 2024	BUY	$40.25 - $52.99 $136,850 - $180,166	3,400 Added 5.18%	69,000 $2.87 Million
Q1 2024 May 10, 2024	SELL	$47.98 - $54.4 $2.37 Million - $2.69 Million	-49,400 Reduced 42.96%	65,600 $3.56 Million
Q4 2023 Feb 13, 2024	BUY	$48.48 - $57.85 $2.92 Million - $3.49 Million	60,300 Added 110.24%	115,000 $5.9 Million
Q3 2023 Nov 13, 2023	BUY	$57.89 - $64.73 $1.46 Million - $1.63 Million	25,200 Added 85.42%	54,700 $3.17 Million
Q2 2023 Aug 10, 2023	BUY	$63.71 - $70.74 $809,117 - $898,397	12,700 Added 75.6%	29,500 $1.89 Million
Q1 2023 May 15, 2023	BUY	$65.71 - $74.53 $551,964 - $626,052	8,400 Added 100.0%	16,800 $1.16 Million
Q4 2022 Feb 14, 2023	BUY	$68.48 - $81.09 $575,232 - $681,156	8,400 New	8,400 $604,000
Q1 2022 May 16, 2022	SELL	$61.48 - $73.72 $2.96 Million - $3.55 Million	-48,200 Closed	0 $0
Q4 2021 Feb 14, 2022	BUY	$53.63 - $62.52 $2.58 Million - $3.01 Million	48,200 New	48,200 $3.01 Million

2,536

1.47B

31.6M

35M

Ticker BMY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,126,160,000
Market Cap $123B
Description
Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...

Get notified when there are updates to the investment portfolio of Delta Accumulation, LLC, based on Form 13F filings with the SEC.

Stay updated on Delta Accumulation, LLC with notifications on news.